TY - JOUR
T1 - An Online Application for Retinoblastoma Surveillance
AU - Singh, Nakul
AU - Debenedictis, Meghan J.
AU - Singh, Arun D.
N1 - Funding Information:
The Cole Eye Institute is supported by an unrestricted grant from Research to Prevent Blindness. The sponsor or funding organization had no role in the design or conduct of this research.
Publisher Copyright:
© 2020
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Background: Retinoblastoma (RB) is a potentially heritable childhood cancer that is vision- and life-threatening. Assessing the risk of inheriting RB is important for structuring ophthalmic and genetic screening of family members. Purpose: To create a free online application that integrates phenotypic, genetic, and familial relationships with clinical best practice surveillance guidelines for families with RB. Methods: The risk of germline RB1 gene mutation was assessed for first- and second-degree relatives of a proband under variable clinical scenarios, integrating age, phenotype, relationship data, and genotype (germline RB1 mutation status: detected, undetected, not tested). Based on the assessed risk of a germline RB1 mutation, recommendations regarding further genetic testing as well as ophthalmic surveillance were derived from consensus guidelines. Results: The recommendations depend on the RB1 germline mutation status (detected, undetected, not tested), which were further subcategorized by the results of tumor phenotype, relationship to proband, age of the relative, and family structure. The online application is available at https://nakul-singh.shinyapps.io/RB_Screening_rec/. Conclusions: The assessed risk of germline RB1 mutation determines ophthalmic surveillance recommendations. The tool may have most value in regions where access to specialized care is limited.
AB - Background: Retinoblastoma (RB) is a potentially heritable childhood cancer that is vision- and life-threatening. Assessing the risk of inheriting RB is important for structuring ophthalmic and genetic screening of family members. Purpose: To create a free online application that integrates phenotypic, genetic, and familial relationships with clinical best practice surveillance guidelines for families with RB. Methods: The risk of germline RB1 gene mutation was assessed for first- and second-degree relatives of a proband under variable clinical scenarios, integrating age, phenotype, relationship data, and genotype (germline RB1 mutation status: detected, undetected, not tested). Based on the assessed risk of a germline RB1 mutation, recommendations regarding further genetic testing as well as ophthalmic surveillance were derived from consensus guidelines. Results: The recommendations depend on the RB1 germline mutation status (detected, undetected, not tested), which were further subcategorized by the results of tumor phenotype, relationship to proband, age of the relative, and family structure. The online application is available at https://nakul-singh.shinyapps.io/RB_Screening_rec/. Conclusions: The assessed risk of germline RB1 mutation determines ophthalmic surveillance recommendations. The tool may have most value in regions where access to specialized care is limited.
KW - Familial relationship
KW - Genetics
KW - Retinoblastoma
KW - Surveillance
UR - http://www.scopus.com/inward/record.url?scp=85082517476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082517476&partnerID=8YFLogxK
U2 - 10.1159/000505751
DO - 10.1159/000505751
M3 - Article
AN - SCOPUS:85082517476
SN - 2296-4681
VL - 6
SP - 376
EP - 380
JO - Ocular Oncology and Pathology
JF - Ocular Oncology and Pathology
IS - 5
ER -